This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Primary Aldosteronism
and you are
over 20
years old
The phase for this study is not defined.
Show me locations

The purpose

To examine antihypertensive effect and safety of CS-3150 in patients with primary aldosteronism.

Provided treatments

  • Drug: CS-3150

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885662. The sponsor of the trial is Daiichi Sankyo Co., Ltd. and it is looking for 44 volunteers for the current phase.
Official trial title:
A Study of CS-3150 to Evaluate Efficacy and Safety in Patients With Primary Aldosteronism